Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3869_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface from the Series Editors
- •Preface from the Editors
- •Contents
- •Planning the Procedure
- •Understanding the Underlying Pathological Process
- •Understanding the Role of Alternative Therapies
- •Contributors
- •Section I
- •1 Basic Principles of Embolization
- •Introduction
- •Underlying Principles
- •Identifying the Target
- •Knowing the Arterial Anatomy and Collateral Pathways
- •Normal Anatomy and Anatomic Variations
- •Collateral Perfusion
- •End Arterial Supply
- •Choosing the Correct Embolic Material
- •Understanding the Likely Outcomes/Consequences of Embolization
- •Performing the Procedure
- •Informing Others: The Patient and Clinicians
- •Planning Vascular Access
- •Selective Catheterization
- •Single End Hole Catheters
- •Avoiding Wedged Catheter Positions
- •Microcatheters
- •Delivery of Embolic Materials
- •Preserving Vessels
- •Non-target Embolization
- •2 Coils, Occluders, and Plugs
- •Introduction
- •Mechanism of Action
- •Intimal Injury and Thrombus Formation Are Interrelated
- •Physical Properties of Embolization Coils and Plugs
- •Materials
- •Novel Materials
- •Material Issues
- •Thrombogenicity
- •Coils Shapes and Sizes
- •Coil Size
- •Terminology
- •Coil Deployment
- •Additional Techniques
- •Detachable Coils
- •Associated Complications and Strategies for Minimizing These
- •Suggested Further Reading
- •3 Permanent Particulate Agents
- •Introduction
- •Particle Physical Properties
- •Commonly Used Agents
- •Polyvinyl Alcohol Particles (PVA)
- •PVA Microspheres
- •Tris-Acryl Microspheres
- •Bio-active Particles
- •Drug-Eluting Microspheres
- •Two Types of Drug-Eluting Microspheres are Available
- •Considerations Relating to 90 Y Microspheres
- •Detectable Microspheres
- •Using Permanent Particulate Agents
- •Preparation of the Agent
- •Injection of the Agent
- •Following Injection
- •Keypoints
- •4 Temporary Embolic Agents
- •Temporary Agents
- •Autologous Blood Clot
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting and Preventing Problems
- •Gelatin Sponge
- •Slurry
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It (Figure 4.1)
- •When and When Not to Use It
- •Detecting Problems
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Dosage and Side Effects
- •When to Use Absolute Alcohol
- •When Not to Use It
- •Sodium Tetradecyl Sulfate
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •N-Butyl Cyanoacrylate
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •Detecting Problems
- •Pledgets
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting Problems
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting Problems
- •5 Liquid Embolic Agents
- •Sclerosing Agents
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use Alcohol
- •When to Use
- •When Not to Use It
- •Note
- •Lipiodol
- •Physical Description and Properties
- •Fate of Injected Lipiodol
- •Lymphatic Injection
- •Hepatic Arterial Injection
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •Suggested Reading
- •6 Miscellaneous Embolic Agents: Laser and Radiofrequency
- •Laser
- •About Lasers
- •Laser Power (Fig. 6.2)
- •Safety
- •Radiofrequency (Fig. 6.3)
- •Monitoring Treatment
- •Applications of Temperature-Induced Vessel Occlusion
- •Keypoints
- •7 Future Embolic Therapies
- •Gene Therapy
- •Mode of Action
- •Mechanisms of Gene Transfer/Modulation
- •Nanoparticles
- •Keypoints
- •Recommended Readings/References
- •8 Vascular Access, for Embolization: Techniques and Equipment
- •Catheter Choice
- •Catheter Properties
- •Catheter Shapes and Technical Tips
- •Reverse Curve Catheters
- •Scenarios
- •Crossing the Aortic Bifurcation
- •Technical Note: Waltman Loop Technique
- •Catheter Characteristics
- •Microcatheters
- •Advantages of Microcatheters
- •Disadvantages of Microcatheters
- •Occlusion Balloons
- •Uses of Occlusion Balloons in Embolization
- •Vascular Sheaths and Guiding Catheters
- •Guidewires
- •Support Wires
- •Exchange Wires
- •Keypoints
- •9 Pre-procedure Imaging: When, Why, and How?
- •Introduction
- •Pre-procedure Imaging: When?
- •Pre-procedure Imaging: Why?
- •Pre-procedure Imaging: How?
- •Imaging Technique
- •Contrast Enhancement
- •Clinical Scenarios
- •Thoracic Embolization
- •Hemoptysis
- •Abdominal Embolization
- •Acute Gastrointestinal Hemorrhage
- •Pre-procedure Imaging: When?
- •Pre-procedure Imaging: Why?
- •Trauma (see also Chapter 10)
- •True Aneurysms of the Visceral Arteries
- •Suggested Further Reading
- •10 Imaging the Severely Injured Patient
- •Introduction
- •Death from Trauma
- •Rationale for Early Imaging
- •Optimal Imaging
- •Image Reconstruction
- •What to Look For
- •What Next?
- •Performing Angiography
- •Considerations for Imaging Departments
- •Radiation Considerations
- •Bibliography
- •Appendix
- •11 Safety in the Periprocedural Period
- •Introduction
- •Pre-procedure
- •Procedural
- •Post-procedural
- •Safe Sedation and Analgesia During the Procedure
- •Staff
- •Equipment
- •Routine Care Equipment
- •Emergency Equipment
- •Medications
- •Complications
- •Anesthesiology Assistance During Sedation and the Use of General Anesthesia
- •Safe Sedation and Analgesia Following the Procedure
- •Contrast-Induced Nephropathy
- •Prevention of CIN
- •Patient Safety and Comfort Are Paramount
- •Suggested Readings
- •12 Complications of Embolotherapy
- •Prevention, Detection, and Recognition
- •Pre-procedure
- •During the Procedure
- •Detection and Recognition
- •During the Procedure
- •Post-procedure
- •Clinical Assessment
- •Blood Tests
- •Imaging
- •Catheters Blocking
- •Non-target Embolization
- •Coil Retrieval
- •Tissue Necrosis
- •13 Management of Post-embolization Syndrome
- •Introduction
- •Pathophysiology
- •Clinical Features
- •Pain
- •Fever
- •Nausea and Vomiting
- •Diagnostic Evaluation
- •Laboratory
- •White Cells
- •Management of PES
- •Prevention
- •Management of PES: Intraprocedural
- •Bibliography
- •Section II
- •14 Peripheral Vascular Malformations
- •Background
- •Low-Flow Lesions
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical Review
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Cautions/Contraindications
- •Anatomy
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Follow-Up
- •High-Flow Lesions
- •Diagnostic Evaluation
- •Clinical Review
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Cautions/Contraindications
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •15 Pulmonary Arteriovenous Malformations
- •Clinical Features
- •Clinical Presentation
- •Clinical Relevance
- •Clinical
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Catheters
- •Selective Catheters
- •Embolic Agents
- •Medication
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •16 Systemic Arteriovenous Fistulae
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Anatomy
- •Equipment
- •Catheters
- •Medications
- •Pain Control
- •Infection Control
- •Sickness Control
- •Hydration
- •Arterial Access
- •Venous Access
- •Assessing the Lesion
- •Angiographic Appearance
- •Clinical Scenarios
- •Etiology of Arteriovenous Fistulae
- •Renal AVF
- •Small Post-biopsy Renal AVF
- •Congenital and Large Renal Arteriovenous Fistulae
- •Arterioportal Fistuale
- •Aortocaval Fistulae
- •Approach
- •Artery
- •Vein
- •Technical Points
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Readings
- •17 Klippel-Trenaunay Syndrome
- •Diagnosis
- •Clinical Features
- •Capillary Malformation (Fig. 17.1)
- •Hypertrophy of Bone and Soft Tissues (Fig. 17.1)
- •Venous Abnormality (Fig. 17.2)
- •Other Features
- •Assessment
- •Management
- •18 Biologic Effects of Tumor Embolization
- •Introduction
- •The Target Tissue
- •The Goal of the Embolization Procedure
- •Biological Effects on the Embolized Tissue/Organ
- •Short Term
- •Hypoxia Inducible Factor 1 (HIF-1)
- •Tumor Lysis Syndrome (TLS)
- •Target of Embolization
- •The Patient
- •The Target Organ
- •Liver
- •Kidney
- •The Disease Process
- •Recommended Reading
- •19 Liver Tumors (Hepatocellular Cancer)
- •Epidemiology of HCC
- •Diagnosis
- •Imaging
- •Differential Diagnosis Includes
- •Laboratory/Other Investigations
- •General Considerations
- •Contraindications
- •Pre-procedure Evaluation
- •Anatomic Considerations
- •Normal Anatomy
- •Variant Anatomy: (See also Table 33.1) (Fig. 19.2)
- •Extra-hepatic Supply (Fig. 19.3)
- •Consent
- •Equipment
- •Catheters
- •Chemotherapeutic Agents
- •Embolic Agent
- •Lipiodol
- •Particulate Agents
- •Drug-Eluting Beads
- •Bland Embolization Versus TACE
- •Radioembolization
- •Selective Versus Non-selective TACE
- •Procedure
- •Pre-procedure Preparation
- •Access
- •Initial Diagnostic Study
- •Selective Angiography
- •Perform Chemoembolization
- •Technique: Lipiodol
- •Technique: Drug-Eluting Beads
- •Endpoints: Two Procedural Endpoints Should be Considered
- •Post-procedure
- •Post-procedure Follow-Up
- •Assess
- •Keypoints
- •Suggested Reading
- •20 Liver Tumors: Metastases
- •Clinical Features
- •Available Embolic Therapies
- •Diagnostic Evaluation
- •Indications
- •Relative Contraindications
- •Anatomy
- •Patient Preparation
- •Pre-procedure Medications
- •Equipment
- •Post-procedure Medications
- •Follow-Up
- •Current Data
- •Alternative Therapies
- •Suggested Reading
- •21 Liver Tumors: Neuroendocrine Hepatic Metastases
- •Clinical Features
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Contraindications
- •Vascular Anatomy
- •Equipment
- •Catheters
- •Medications
- •IR Evaluation
- •Access
- •Arteriography
- •Assessing the Lesions
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Aftercare
- •Arterial Access Site
- •Post-embolization
- •Follow-Up
- •Suggested Reading/References
- •22 Embolization of Benign and Malignant Renal Tumors
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Indications
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Pre-operative Embolization
- •Embolization in Patients with Inoperable Cancer
- •Embolization in AML
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Alternative Therapies
- •Keypoints
- •Safety
- •Suggested Reading
- •23 Embolization of Bone Tumors
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging (Fig. 23.1)
- •Indications
- •Alternative Therapies
- •Contraindications (Relative)
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Pre-operative Embolization (Fig. 23.2)
- •Palliative Embolization
- •Embolization as a Primary Treatment
- •Complications
- •Post-embolization Syndrome
- •Follow-Up
- •24 Uterine Fibroid Embolization
- •Clinical Features
- •Diagnostic Evaluation
- •Gynecologic Examination
- •Laboratory
- •Transvaginal Ultrasound (TVUS)
- •Indications
- •Contraindications
- •Aberrant Anatomy
- •Pre-treatment Patient Information
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Angiographic Appearance
- •Re-embolization of Uterine Artery
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Treatment Failures
- •Suggested Reading
- •Appendix
- •25 Embolization of Hemorrhage Due to Pelvic Fractures
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging (see also Chapter 10)
- •Indications
- •Contraindications
- •Complications
- •Anatomy
- •Equipment
- •Catheters Required
- •Angiography (See Figs. 25.1 and 25.2)
- •Recommendations
- •Suggested Reading
- •26 Embolization of Extremity Trauma
- •Clinical Features
- •Management Goals
- •Mechanisms of Extremity Vascular Injury
- •Clinical Manifestations of Extremity Vascular Trauma
- •Role of Intervention
- •Diagnostic Evaluation
- •Clinical Evaluation
- •Physical Signs of Vascular Injury
- •Imaging
- •Radiographs
- •Indications
- •Alternative Therapies
- •Anatomy
- •Aberrant Anatomy
- •Variant Anatomy of Lower Extremity
- •Equipment
- •Catheters
- •Non-selective
- •Selective Catheters
- •Guide Catheters and Sheaths
- •Embolic Agents
- •For Dispensable Branch Vessels
- •For Indispensable Vessels
- •Medication
- •Angiography
- •Access
- •Angiographic Appearance
- •Positive Findings of Vascular Injury
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Consider
- •Special Considerations
- •Upper Limb
- •Lower Limb
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •27 Solid Organ Embolization in Trauma
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •The Importance of Blood Pressure in the Context of Trauma
- •Imaging (See Also Chapter 10)
- •Abdominal Ultrasound (FAST)
- •Contrast-Enhanced CT
- •Imaging Findings: The Following Predict the Need for Intervention
- •Indications
- •Alternative Therapies
- •Surgery
- •Contraindications
- •Complications
- •Anatomy
- •Normal Anatomy and Common Variations
- •Equipment
- •Embolic Agents
- •Rarely Required
- •Medication
- •Access
- •Angiography
- •Angiographic Appearance
- •Embolization
- •Liver
- •Complications of Hepatic Embolization
- •Spleen
- •Complications of Splenic Embolization
- •Kidney
- •Complications of Renal Embolization
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Keypoints
- •28 Post-traumatic Priapism
- •Clinical Features
- •Low-Flow Priapism
- •High Flow or Arterial Priapism
- •Diagnostic Evaluation
- •Laboratory
- •Cavernosal Blood Gas Analysis
- •Imaging
- •Color Doppler Imaging of the Penis
- •Indications
- •For Angiography
- •For Embolization
- •Alternative Therapies
- •Cautions
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Angiographic Appearance
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Safety
- •Suggested Reading
- •29 Embolization for Pancreatic Bleeding
- •Clinical Features
- •Hemorrhage in Pancreatitis
- •Hemorrhage Following Pancreatic Surgery
- •Imaging
- •Indications for Imaging and Embolization
- •Contraindications
- •Anatomy
- •Angiography and Embolization Equipment
- •Embolic Agents
- •Procedure Access
- •Angiography
- •Angiographic Appearance
- •Embolization for Post-pancreatitis Aneurysm and Pseudoaneurysm
- •Embolization for Post-operative Bleeding
- •Aftercare
- •Puncture Site
- •Post-embolization
- •Follow-Up
- •Safety
- •Bibliography
- •30 Embolization in Post-operative Hemorrhage
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Surgical Repair
- •Alternative Interventional Techniques
- •Contraindications
- •Anatomic Considerations
- •Equipment
- •Medication
- •Systemic
- •Transcatheter
- •Procedure
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Unstable Patients
- •Coagulopathic Patients
- •Active Extravasation
- •Pseudoaneurysm
- •Iatrogenic Injury During Central Line Placement
- •Post-embolization
- •Follow-Up
- •Repeat CT
- •Keypoints
- •Safety
- •Suggested Reading
- •31 Tract Embolization
- •General Concepts
- •Pre-procedure Evaluation
- •Indications for Tract Embolization
- •Contraindications
- •Material Selection
- •Operator Preference
- •Gelfoam
- •Metallic Coils
- •N-Butyl Cyanoacrylate
- •Autologous Clotted Blood/Blood Patch
- •Post-procedure Management
- •Complications
- •Results
- •Keypoints
- •References
- •32 Arterial Embolization Post-percutaneous Biopsy or Drainage
- •General Considerations
- •Bleeding Around Drains
- •Drainage Catheter Upsizing
- •Bleeding Following Biopsy
- •Risk Factors
- •Pre-procedure Evaluation
- •Patient Evaluation
- •Imaging
- •Laboratory
- •Indications for Embolization
- •Contraindications to Embolization
- •Treatment Plan and Technique
- •Pseudoaneuryms and Active Bleeding
- •Materials
- •Catheters and Microcatheters and Guidewires
- •Embolization Materials
- •Medications
- •Complications
- •Anatomy of the Lesion
- •Hematomas
- •Arteriovenous, Arterioportal, or Arteriobiliary Fistulae
- •Pseudoaneurysm
- •Bile Leaks
- •Vascular Anatomy
- •Native Liver
- •Transplanted Livers
- •Procedure/Steps
- •Embolization
- •Results
- •Complications
- •Renal Embolization Post-percutaneous Biopsy/Drainage
- •Anatomy of the Lesion
- •Hematomas
- •Arteriovenous Fistula (see Chapter 16)
- •Pseudoaneurysm
- •Vascular Anatomy
- •Native Kidneys
- •Transplanted Kidneys
- •Procedure/Steps
- •Native Kidneys
- •Transplant Kidneys
- •Results
- •Complications
- •Fatal Complication
- •Procedural Complication
- •Anatomy of the Lesion
- •Source of Bleeding
- •Imaging Findings
- •Vascular Anatomy
- •Procedure/Steps
- •Procedure Preparation
- •Angiography
- •Embolization
- •Results
- •Complications
- •Bibliography
- •33 Acute Nonvariceal Upper Gastrointestinal Hemorrhage
- •Clinical Features
- •Causes
- •Laboratory
- •Endoscopy
- •Imaging
- •Triple-Phase Multidetector Computed Tomography Angiography (CTA)
- •Indications for Embolization
- •Contraindications to Embolization
- •Anatomy
- •Embolic Agents
- •Procedure
- •Treatment Plan
- •Access
- •Angiography
- •Assessing the Lesion
- •Location
- •Gastric Bleeding
- •Duodenal Bleeding
- •Arterial Puncture Site
- •Follow-up
- •Alternative Therapies
- •Bibliography
- •34 Acute Lower Gastrointestinal (GI) Hemorrhage
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Tc-99 M RBC Study
- •Indications
- •Anatomy
- •Normal Anatomy
- •Anatomic Variation
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Treatment Plan and Technique
- •Embolization
- •Follow-Up
- •Alternative Therapies
- •Suggested Reading
- •35 Bronchial Artery Embolization
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Life-Threatening Hemoptysis
- •BAE Should Also Be Considered in
- •Adjunctive and Alternative Therapies
- •Contraindications
- •All Complications Are Minimized by
- •Anatomy
- •Normal Bronchial Artery Anatomy
- •Key Points in Bronchial Arteriography
- •Aberrant/Variant Anatomy
- •Equipment
- •Catheters
- •Non-selective Catheters
- •Selective Catheters
- •Sheaths and Guide Catheters
- •Embolic Agents
- •Medication
- •Infection Control
- •Hydration
- •Angiography
- •Access and Angiography
- •Angiographic Appearance
- •Next, Identify Any Spinal Supply That
- •Embolization
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •36 Pulmonary Hemorrhage (Non-bronchial)
- •Etiology
- •Causes of Pulmonary Arterial Hemorrhage
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Catheters
- •Embolic Agents
- •Medications
- •Procedure
- •Pulmonary Angiography
- •Assess Bleeding
- •Embolization
- •Suggested Reading
- •37 Endoleaks Following EVAR
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Catheters
- •Embolic Agents
- •Medication
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Suggested Readings
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Equipment
- •Catheters
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Iliac Artery
- •Angiographic Appearance
- •Clinical Scenarios
- •Pre-EVAR Embolization
- •Embolization in Patients with IIAA
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •39 Embolization of Visceral Arterial Aneurysms
- •Clinical Features
- •Natural History
- •Clinical Presentation
- •Rupture
- •Splenic Artery
- •Hepatic Artery
- •Celiac Artery
- •Superior Mesenteric Artery
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Indications for Treatment
- •Contraindications to Treatment
- •Relevant Anatomy
- •Normal Anatomy ( ≈ 50%)
- •Aberrant Anatomy (≈ 44% with One Arterial Variant, ≈ 6% with Two Arterial Variants)
- •Equipment
- •Medication
- •Procedure
- •Alternative Therapies
- •Suggested Reading
- •40 Renal Artery Aneurysms
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Treatment Indications
- •Contraindications
- •Equipment
- •Procedure
- •Access
- •Angiography
- •Assessing Lesions
- •Forming a Treatment Plan
- •Covered Stent
- •Balloon Remodeling
- •Bare Stent Assisted
- •Primary Coiling
- •Performing the Embolization
- •Embolization Endpoint
- •Immediate Post-procedure Care
- •Long-Term Follow-Up
- •Results
- •Alternative Therapies
- •In Vivo Aneurysmectomy
- •Ex Vivo Resection and Autotransplant
- •Nephrectomy
- •Complications
- •Keypoints
- •Suggested Reading
- •41 Pre-operative Portal Vein Embolization
- •Pre-operative Portal Vein Embolization
- •Clinical Features
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Alternatives Include
- •Medications
- •Angiography
- •Access
- •Angiography
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Spontaneous Epistaxis
- •Treatment Plan and Technique
- •Additional Considerations
- •Follow-Up
- •Suggested Reading
- •42 Epistaxis
- •Clinical Features
- •Diagnostic Evaluation
- •Nasal Endoscopy
- •Imaging
- •Laboratory
- •Management of Epistaxis
- •Initial Therapy
- •Indications for Embolization
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Equipment
- •Catheters
- •Hereditary Hemorrhagic Telangiectasia
- •Trauma Including Traumatic Pseudoaneurysms
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Bibliography
- •43 Meningiomas and Paragangliomas
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Alternative Therapies
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Strategy
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Location
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Keypoints
- •Safety
- •Clinical Features
- •Diagnostic Evaluation
- •Imaging/Investigation
- •Females with Pelvic Pain
- •Males with Varicocele
- •Indications
- •Females
- •Males
- •Male Varicocele
- •Contraindications
- •General
- •Complications
- •Anatomy
- •Normal Anatomy
- •Female
- •Male
- •Aberrant Anatomy
- •Catheters
- •Embolic Agents
- •Medication
- •Venography
- •Access
- •Venography
- •Transfemoral Route
- •Angiographic Appearance
- •Ovarian Vein
- •Spermatic Vein
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Ovarian Vein
- •Spermatic Vein
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Readings
- •45 Varicose Veins
- •Clinical Features
- •Natural History of Varicose Veins
- •Diagnostic Evaluation
- •Imaging
- •Indications for Treatment
- •Surgery
- •Contraindications
- •General Complications of Venous Ablation Therapy
- •Anatomy and Physiology
- •Normal Venous Anatomy
- •Normal Lower Limb Venous Physiology
- •Equipment
- •Imaging
- •Needles
- •Guidewires
- •Catheters/Introducer Sheaths
- •Miscellaneous
- •Medication
- •Treatment Plan and Technique
- •Thermal Ablation Therapy
- •Laser Therapy
- •Laser Equipment
- •Access
- •Treatment Technique
- •Radiofrequency Ablation Therapy
- •Radiofrequency Devices
- •Technique
- •Foam Sclerotherapy
- •Clinical Scenarios
- •Varicosities
- •Foam Sclerotherapy
- •Avulsions
- •Prominent Veins in Other Sites
- •Aftercare
- •Follow-Up
- •Safety
- •Suggested Reading
- •46 Lymphatic Malformations: Sclerotherapy
- •Clinical Features and Presentation
- •Occurrence
- •Manifestations
- •Diagnostic Evaluation
- •Imaging
- •Other Cystic Lesions in the Head and Neck
- •Treatment Options
- •Evidence for Sclerotherapy
- •Anatomy
- •Equipment
- •Catheters
- •Bleomycin
- •Doxycycline
- •Medication
- •Treatment Plan and Technique
- •Children
- •Technique
- •Follow-Up
- •Safety
- •Recommended Further Reading
- •47 Thoracic Duct Embolization
- •Diagnostic Evaluation/Laboratory
- •Imaging
- •Indications
- •Medical Therapies
- •Contraindications
- •Anatomy
- •Anatomic Variation
- •Equipment
- •Embolic Agents
- •Procedure
- •Preparation
- •Pedal Lymphography
- •Access
- •Treatment Plan and Technique
- •Embolization
- •Disruption of Lymph Channels
- •Case Example (Fig. 47.2)
- •Follow-Up
- •Suggested Reading
- •48 Post-partum Hemorrhage: Embolization and Endovascular Management
- •Clinical Features
- •Diagnostic Evaluation
- •Imaging
- •Indications for Intervention/Embolization
- •Contraindications to Intervention/Embolization
- •Anatomy
- •Equipment
- •Embolic Agents
- •Procedure
- •Therapeutic Embolization for Acute PPH
- •Access
- •Angiography
- •Embolization (See Fig. 48.1)
- •Prophylactic Interventions
- •Access
- •Angiography
- •Embolization
- •Arterial Puncture Site
- •Follow-Up
- •Alternative Therapies
- •Suggested Reading
- •Index

422 A.M. Papadopoulou and A. Platts
• Most commonly, the precise site of bleeding is not known. Bilateral IMA
embolization with particles is necessary in such cases because of the side-to-side
anastomoses that can be recruited to the bleeding nasal mucosa. The microcatheter should be advanced distal to branches with high potential for dangerous
anastomosis collaterals such as the middle meningeal, accessory meningeal, and
superficial temporal arteries to avoid non-target embolization.
• For patients with an anterior source of bleeding, particle embolization of the nasal
branches of the facial artery should also be performed carefully so that the distal
supply of the terminal alar artery, which supplies the skin of the nasal ala, is
preserved.
• Catheter-induced vasospasm is a common occurrence with superselective
catheterization of ECA branches. This significantly alters flow distally, even to
the point of stasis. Gentle microcatheter manipulation and minimal guidewire
manipulation can minimize vasospasm. Glycerine trinitrate (GTN 50–500 μg)
can be administered to treat vasospasm after the catheter has been retracted
proximal to the point of vasospasm.
• Liquid embolic agents (NBCA, Onyx
tinely because of the risk of non-target embolization or tissue necrosis. Their
use has been advocated in rare cases where a focal angiographic abnormality or
extravasation is demonstrated but the feeding vessel cannot be catheterized.
TM
) are not recommended for use rou-
Juvenile Nasal Angiofibroma
• PVA particles are the agent of choice in the pre-operative embolization of juvenile
nasal angiofibroma.
• The goal is to obliterate the capillary bed while preserving normal tissue.
Hereditary Hemorrhagic Telangiectasia
• Approach similar to that for spontaneous epistaxis with bilateral IMA
embolization.
• There is a higher recurrence rate and need for re-intervention.
Trauma Including Traumatic Pseudoaneurysms
• Coils or covered stents may be used in the case of pseudoaneurysms.
Aftercare
Arterial Puncture Site
• A closure device is useful when the patient has been anti-coagulated during the
procedure.

42 Epistaxis 423
Post-embolization
• No specific care is needed.
• Do not forget the following:
◦ To continue resuscitation/transfusion as necessary
◦ To manage risk factors
◦ That rebleeding is common
Follow-Up
No routine follow-up needed.
Keypoints
• Epistaxis can result from a multitude of causes, the commonest being the
spontaneous or idiopathic form.
• Embolotherapy in the management of spontaneous epistaxis is reserved for
cases refractory to topical or conservative measures.
• Embolotherapy is essential prior to some endoscopic tumor resection
procedures.
Safety
• Knowledge of the arterial anatomy, the angiographic and embolization
technique, and potential complications and how to avoid these are imperative for ensuring a good outcome.
Bibliography
Gifford TO, Capt MC, Orlandi, RR. Epistaxis. Otolaryngol Clin N Am 2008; 41: 525–536.
Mahadevia AA, Murphy KJ, Obray R, Gailloud P. Embolization for intractable epistaxis. Tech
Vasc Interventional Rad 2005; 8:134–138.
Nguyen QA. Epistaxis eMedicine http://www.emedicine.com/ent/TOPIC701.HTM
Smith T. E mbolization in the external carotid artery. J Vasc Interv Radiol 2006; 17:1897–1913.

Chapter 43
Meningiomas and Paragangliomas
H.L.D. Makalanda and Andrew Platts
Clinical Features
• Meningiomas are extra-axial brain tumors derived from arachnoid cells of neu-
ral crest origin. They comprise 20% of primary intra-cranial tumors and are
more common in older patients and women (M:F = 2:1). They also have some
syndromal associations.
• Paragangliomas (glomus tumors) arise from neural crest cells and typically arise
at four locations and are as follows:
Carotid body (caroticum)
Jugular foramen of the temporal bone (jugulare)
Tympanic plexus (tympanicum)
Vagal nerve (vagale)
◦ They are slow growing and most frequently found in women of the fifth and
sixth decade.
◦ May be multifocal in as many as 22% of patients.
• The optimal treatment for these tumors is complete resection where possible.
Pre-operative embolization reduces operative time and intra-operative blood loss
when resecting these vascular tumors. It provides a particularly useful adjunct
when the tumors exhibit hypervascularity or when they encase vital structures.
Diagnostic Evaluation
Laboratory
As for any angiographic examination (e.g., clotting and renal profiles).
Transcatheter Embolization and Therapy,
Techniques in Interventional Radiology, DOI 10.1007/978-1-84800-897-7_43,
C
Springer-Verlag London Limited 2010
425

426 H.L.D. Makalanda and A. Platts
Imaging
• Never start embolization until you have formally reviewed the pre-procedure
imaging.
• Use contrast-enhanced CT/MRI with multi-planar reformats to
◦ Establish diagnosis (differential diagnosis: hemangiopericytoma, angiosar-
coma).
◦ Demonstrate location and tumor extent.
◦ Assess operability.
◦ Assess tumor vascularity.
◦ Delineate tumor extension to
◦ Major arteries
◦ Major veins
◦ Cranial nerves
◦ Dural venous sinuses
◦ Calvarium
Use angiography to
• Plan embolization by identifying feeding vessels (dural and pial) and assess
feasibility and safety of embolization.
• Detect arterio-arterial anastamoses, abnormal branches, or trans-osseous
supply.
• Assess the collateral circulation to the brain.
• Assess the intensity of tumor staining and flow characteristics.
• Acquire information about the venous drainage, any cortical venous changes, and
patency of adjacent major dural venous sinuses.
Indications
• Pre-operative embolization: making the tumors smaller, softer, and less bloody
allowing easier manipulation and removal at surgery. Embolization of the ECA
branches controls deep hemorrhagic sites. Pial bleeding is usually easy to control
surgically.
• Stand-alone embolotherapy of tumors has been reported in a small series, but is
rarely performed.
Contraindications
• Renal insufficiency and coagulopathy are relative contraindications, and should
ideally be corrected before this semi-elective procedure is performed.

43 Meningiomas and Paragangliomas 427
• Gadolinium may be used in patients with a true allergic reaction to iodinated
contrast.
Alternative Therapies
Direct injection of liquid embolic agents into hypervascular paragangliomas has
TM
been proven safe and efficacious in some studies. Both NBCA and Onyx
have
been used.
Specific Complications
These include non-target embolization causing the following:
• Stroke
• Blindness
• Cranial nerve palsy
Anatomy
Assess the vascular supply on the pre-procedural imaging. Multiple vessels supplying the tumor indicate that the case will take longer to perform. The anatomy is
markedly variable depending upon tumor location.
Normal Anatomy
• Commonly supplied by the dural arteries. These include the following:
◦ External carotid artery branches
Middle meningeal (MMA)
Accessory meningeal
Ascending pharyngeal—of particular importance in paragangliomas
Occipital transmastoid
◦ Internal carotid artery (ICA) branches
Tentorial
Inferolateral trunk
◦ Vertebral artery branches
Posterior meningeal
• All these branches need to be assessed to exclude aberrant anatomy. However,
the feeding arteries can often be deduced from the tumor location (Tables 43.1
and 43.2).

428 H.L.D. Makalanda and A. Platts
Table 43.1 Meningioma location and supply
Meningioma l ocation Supply
Falx/parasagittal/convexity MMA—usually ECA occasionally from ICA—ophthalmic
Sphenoid wing MMA—usually ECA occasionally from ICA—ophthalmic
Olfactory
groove/planum
sphenoidale
Parasellar/pertroclinoid/
petrous apex
Tentorium Tentorial artery—ICA branch
Infratentorial Tentorial artery—ICA branch
Abbreviations: MMA—middle meningeal artery; ECA—external carotid artery; ICA—internal
carotid artery; VA—vertebral artery
Anterior falx artery—usually from ICA –ophthalmic
Superficial temporal artery –ECA
Anterior ethmoidal branches—usually from ICA –ophthalmic
Direct supply from pial branches of ICA
Meningo-hypophyseal artery—from cavernous ICA
Middle cranial fossa meningeal branches from ophthalmic
Usually from ICA—ophthalmic, anterior, and posterior ethmoidal
branches.
MMA—usually ECA occasionally from ICA –ophthalmic
MMA—usually ECA occasionally from ICA –ophthalmic
Dorsal meningeal from VA
Occipital artery from ECA
Ascending pharyngeal from ECA
MMA—usually ECA occasionally from ICA –ophthalmic
Occipital artery from ECA
MMA—usually ECA occasionally from ICA—ophthalmic
Occipital artery from ECA
Ascending pharyngeal from ECA
Dorsal meningeal from VA
Cerebellar branches from vertebral and basilar arteries
Table 43.2 Paraganglioma location and supply
Glomus caroticuum ICA and ECA supply
Glomus vagale ICA and ECA supply particularly ascending pharyngeal
Glomus jugulare VA branches
Glomus tympanicum VA branches
ECA branches occipital, post-auricular, MMA, posterior
division of ascending pharyngeal
ECA branches occipital, post-auricular, MMA, posterior
division of ascending pharyngeal
Aberrant Anatomy
Secondary supply may be derived from pial branches and are as follows:
• Anterior cerebral artery (ACA)
• Middle cerebral artery (MCA)
• Posterior cerebral artery (PCA)

43 Meningiomas and Paragangliomas 429
Strategy
• The goal is to reduce the tumor vascularity, thereby reducing surgical blood loss
and dissection time.
• The most important vessels to devascularize are those that feed the tumor deep
to the surgical approach. There is little point in embolizing the middle meningeal
or superficial temporal supply to a convexity meningioma when the surgical
exposure will result in these branches being clipped early during the surgical
approach.
• Pial branches from the ICA are not normally embolized, since the risk of nontarget embolization and stroke is unacceptably high.
Equipment
• Roadmap capability
• Non-selective catheters: none required.
• Selective catheters: vertebral, Sidewinder 2. Microcatheter for selective emboli-
zation.
• Guide catheter: 6Fr with 0.067 lumen allowing guiding contrast injections,
as well as constant flush by attaching to a pressurized heparinized saline bag
via a rotating hemostatic valve. This ensures that the dead space around the
microcatheter is flushed and clot accumulation is prevented.
Embolic Agents
• Polyvinyl alcohol (PVA) particles—300–500 μm, unless shunting or very large
vascular tumor are present in which case larger particles should be used.
• Acrylic polymer microspheres (Embospheres)—300–500 μm unless shunting or
very large vascular tumor when larger particles may be used.
• Coils – may be placed within the MMA proximal to the tumor bed, allowing
easier surgical transection of the artery.
Medication
• General anesthesia: addresses both patient compliance and analgesic require-
ment during the procedure. If provocative testing is to be employed, the procedure
must be performed under local anesthetic with mild sedation.
• Heparin: 5000 IU bolus with 1000 IU per hour thereafter during the embolization
procedure.

430 H.L.D. Makalanda and A. Platts
• Lidocaine: can be used as a provocative test to ensure safe catheter placement
prior to embolization. Inject 1 ml of 1% plain lidocaine and check that the patient
does not develop a cranial nerve palsy or facial sensory change.
• Pain control: analgesia should be prescribed for the recovery period.
• Sickness control: anti-emetics should also be prescribed to control symptoms of
post-embolization syndrome.
Procedure
Access
• Plan according to the pre-operative imaging.
• Almost always approached from the common femoral artery
Angiography
• Selective six-vessel angiography (both ICA, ECA, and vertebrals) can be helpful
in patients with large tumors when the blood supply may not derive exclusively from a single branch, and when the exact supply is unclear from the
pre-procedure imaging.
• The following must be identified and examined to avoid potentially disastrous
complications.
• The distal internal maxillary artery (potential communication with the ICA).
• The neuromeningeal trunk of the ascending pharyngeal artery (supply to 9th,
10th, and 11th cranial nerves).
• The odontoid branch of the ascending pharyngeal artery (potential vertebral
artery anastamosis).
• Meningolacrimal branch of the MMA (potential retinal supply).
• Pre-embolization testing by injection of a small-dose of lidocaine (1 ml 1% plain
lidocaine without epinephrine or buffer) may be used to identify that the blood
supply to cranial nerves is not jeopardized.
• Temporary cranial nerve deficit increases the risk of embolization.
• After the microcatheter has been properly and safely positioned, embolic
material is injected under constant, real-time digital-subtraction fluoroscopy
(road map). This optimizes visualization of tumor staining and filling of nontarget vessels to allow penetration of the material into the tumor bed thereby
producing devascularization and subsequent necrosis.[/l1]
• The pial supply is generally not embolized pre-operatively (due to the risk of
CVA).

43 Meningiomas and Paragangliomas 431
Assessing the Lesion
Location
• The location of the tumor should be known from the pre-operative imaging.
a
c
b
d
Fig. 43.1 (a) External carotid artery DSA images demonstrating a hypervascular left middle cra-
nial fossa meningioma supplied by enlarged posterior ethmoidal and middle meningeal arteries.
Note the typical DSA sunburst tumor blush pre-embolization. (b) Corresponding CT image. (c)
Post-embolization. Tumor vascularity is markedly reduced post-embolization. (d) CT illustrates
the tumor necrosis post-embolization and prior to surgery

432 H.L.D. Makalanda and A. Platts
Fig. 43.2 DSA images of
right common carotid artery
angiograms demonstrating a
right glomus jugulare tumor
(white arrowheads)(a)pre-
(b) post (right) embolization.
Note the pruning of
peripheral vessels
post-embolization
a
b
Angiographic Appearance
• A typical starburst blush pattern identifies the tumor (Figs. 43.1 and 43.2).
Treatment Plan and Technique
The treatment plan and embolic agent depends on the tumor anatomy and operator
experience.
• The goal is to obliterate the tumor capillary bed to produce devascularization of
the tumor while preserving normal tissue. Occluding the feeding artery confers
little benefit over surgical ligation of these vessels intra-operatively.
• When the flow of embolic particle begins to slow, embolization is halted to
prevent reflux of particles into non-target territories.
• Always try and embolize as selectively as possible using microcatheters to navigate into each feeding vessel. PVA particles or acrylic microspheres are used to
embolize as distally as possible.
• The catheter must not be wedged. Flow around the microcatheter delivers the
embolic agent to the target without undue pressurization.
• Embolization is complete when the majority of tumor flow has been obliterated—
remember that the goal is to try to make the surgery simpler by reducing blood
supply from branches of the ECA. Benefit vs. risk of embolizing a particular
vessel should always be considered.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
